2025 HCPCS Code C9800
Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies
TAGS: supplies sculptra syndrome items radiesse facial provision dermal injection lipodystrophy| Notice | HCPCS C9800 terminated on December 31, 2016. |
| Short Description | Dermal filler inj px/suppl |
| Product Note | 0093 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | July 01, 2010 |
| HCPCS Action Effective Date | January 01, 2017 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9472 - Inj talimogene laherparepvec
- C9473 - Injection, mepolizumab
- C9474 - Inj, irinotecan liposome
- C9475 - Injection, necitumumab
- C9476 - Injection, daratumumab
- C9477 - Injection, elotuzumab
- C9478 - Injection, sebelipase alfa
- C9479 - Instill, ciprofloxacin otic
- C9480 - Injection, trabectedin
- C9481 - Injection, reslizumab
- C9482 - Sotalol hydrochloride iv
- C9483 - Injection, atezolizumab
- C9484 - Injection, eteplirsen
- C9485 - Injection, olaratumab
- C9486 - Inj, granisetron ext
- C9487 - Ustekinumab iv inj, 1 mg
- C9488 - Conivaptan hcl
- C9489 - Injection, nusinersen
- C9490 - Injection, bezlotoxumab
- C9491 - Injection, avelumab
